Fengge Song
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fengge Song has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Yi Wan
Department of Health Service, Fourth Military Medical University, Xi’an, Shaanxi, China
8 shared publications Xiufen Yang
4 shared publicationsHaimei Mao
Products Quality Supervision and Testing Institute of Hainan Province, Haikou, China
3 shared publicationsYangdao Wei
Department of Clinical Hematology and Institute of Materia Medica, College of Pharmacy and Laboratory Medicine Science, Army Medical University, Chongqing, China
3 shared publications- Buhua Wang
School of Marine Sciences (State Key Laboratory of Marine Resource Utilization in South China Sea), School of Marine Biology and Fisheries, Hainan University, Haikou, China
2 shared publications - Chuanbin Mao
Department of Biomedical Engineering The Chinese University of Hong Kong Hong Kong SAR China
2 shared publications
Latest Publications
- 16 July 2026
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1420
CRISPR/Cas12a dual-gRNA assay enables precise detection of single-nucleotide mutations via cis-staggered-cleavage
- 16 July 2026
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1420
CRISPR/Cas12a dual-gRNA assay enables precise detection of single-nucleotide mutations via cis-staggered-cleavage
- Open Access
- 12 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
PRICE: direct and robust detection of microRNAs at single-nucleotide resolution
Accurate single-nucleotide discrimination of miRNA is clinically vital because small sequence variations can have significant phenotypic and clinical consequences, yet existing techniques can only detect single nucleotide variations (SNVs) at specific loci. Here, we present a generalized peptide nucleic acid ( P NA) mediated C RI SPR/ C as13a syst e m (PRICE), enabling detection of SNVs in miRNA sequence without sacrificing the sensitivity. PRICE utilizes PNA blockers fully complementary to non-target miRNAs (e.g., miRNAs containing SNVs at loci of no interest) but not to the target miRNA. These blockers selectively hybridize with and inhibit non-target sequences in samples (serum, cells, or tissues). Only the unhybridized target miRNA then binds to crRNA within the Cas13a complex, activating Cas13a to cleave a fluorescent reporter-quencher linker, generating a detectable signal (~10 fM limit). By designing a panel of PNAs against SNVs, PRICE provides a versatile, amplification-free platform for precise miRNA analysis, advancing cancer diagnosis, prognosis, and biology.
- 12 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessPRICE: direct and robust detection of microRNAs at single-nucleotide resolution
Accurate single-nucleotide discrimination of miRNA is clinically vital because small sequence variations can have significant phenotypic and clinical consequences, yet existing techniques can only detect single nucleotide variations (SNVs) at specific loci. Here, we present a generalized peptide nucleic acid ( P NA) mediated C RI SPR/ C as13a syst e m (PRICE), enabling detection of SNVs in miRNA sequence without sacrificing the sensitivity. PRICE utilizes PNA blockers fully complementary to non-target miRNAs (e.g., miRNAs containing SNVs at loci of no interest) but not to the target miRNA. These blockers selectively hybridize with and inhibit non-target sequences in samples (serum, cells, or tissues). Only the unhybridized target miRNA then binds to crRNA within the Cas13a complex, activating Cas13a to cleave a fluorescent reporter-quencher linker, generating a detectable signal (~10 fM limit). By designing a panel of PNAs against SNVs, PRICE provides a versatile, amplification-free platform for precise miRNA analysis, advancing cancer diagnosis, prognosis, and biology.
- 1 January 2026
- Published by Hainan University in Natural Science of Hainan University
- Vol. 45
Characterization of a Mesophilic Argonaute Nuclease for in vitro Cleavage and Its Potential Application in MRSA Gene Detection
随着水产品生产和加工的不断发展,耐药微生物及其基因带来的安全风险逐渐引起关注。基于基因编辑系统的分子传感器,特别是无需原间隔区邻近基序(protospacer adjacent motif, PAM)位点的Argonaute蛋白,已成为核酸检测的重要发展方向。为获取中温性Argonaute核酸酶CbAgo(Clostridium butyricum Argonaute)蛋白并验证其在人源耐药机会致病菌检测中的可行性,本研究采用pET-28a/Rosetta(DE3)表达体系,在0.1 mmol·L−1 IPTG、16 ℃下诱导表达16 h,成功获得了可溶性重组CbAgo蛋白。经镍柱纯化获得约分子量约为87 kDa的CbAgo蛋白。结果表明,CbAgo蛋白能够在引导DNA(Guide DNA, gDNA)引导下特异性识别并切割单链DNA,进一步优化反应体系后,成功实现模拟人源耐药机会致病菌单链核酸片段的切割释放。因此,CbAgo蛋白有望应用于后续海洋环境中人源耐药机会致病菌现场检测及基因编辑研究。
- 1 January 2026
- Published by Hainan University in Natural Science of Hainan University
- Vol. 45
Characterization of a Mesophilic Argonaute Nuclease for in vitro Cleavage and Its Potential Application in MRSA Gene Detection
随着水产品生产和加工的不断发展,耐药微生物及其基因带来的安全风险逐渐引起关注。基于基因编辑系统的分子传感器,特别是无需原间隔区邻近基序(protospacer adjacent motif, PAM)位点的Argonaute蛋白,已成为核酸检测的重要发展方向。为获取中温性Argonaute核酸酶CbAgo(Clostridium butyricum Argonaute)蛋白并验证其在人源耐药机会致病菌检测中的可行性,本研究采用pET-28a/Rosetta(DE3)表达体系,在0.1 mmol·L−1 IPTG、16 ℃下诱导表达16 h,成功获得了可溶性重组CbAgo蛋白。经镍柱纯化获得约分子量约为87 kDa的CbAgo蛋白。结果表明,CbAgo蛋白能够在引导DNA(Guide DNA, gDNA)引导下特异性识别并切割单链DNA,进一步优化反应体系后,成功实现模拟人源耐药机会致病菌单链核酸片段的切割释放。因此,CbAgo蛋白有望应用于后续海洋环境中人源耐药机会致病菌现场检测及基因编辑研究。
- 19 November 2025
- Published by Elsevier in Cell Systems
- Vol. 16 (11) , 101455
Lighting up hidden microbial enzyme diversity and functional opportunities from fermented foods
- 19 November 2025
- Published by Elsevier in Cell Systems
- Vol. 16 (11) , 101455
Lighting up hidden microbial enzyme diversity and functional opportunities from fermented foods
- 29 October 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 293, 118158
Dynamic biosensing enables amplifier-collateral-cleavage enhancement for pathogen diagnostic
- 29 October 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 293, 118158
Dynamic biosensing enables amplifier-collateral-cleavage enhancement for pathogen diagnostic
- Top Cited PapersOpen Access
- 26 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Ultrasensitive detection of clinical pathogens through a target-amplification-free collateral-cleavage-enhancing CRISPR-CasΦ tool
Clinical pathogen diagnostics detect targets by qPCR (but with low sensitivity) or blood culturing (but time-consuming). Here we leverage a dual-stem-loop DNA amplifier to enhance non-specific collateral enzymatic cleavage of an oligonucleotide linker between a fluophore and its quencher by CRISPR-CasΦ, achieving ultrasensitive target detection. Specifically, the target pathogens are lysed to release DNA, which binds its complementary gRNA in CRISPR-CasΦ to activate the collateral DNA-cleavage capability of CasΦ, enabling CasΦ to cleave the stem-loops in the amplifier. The cleavage product binds its complementary gRNA in another CRISPR-CasΦ to activate more CasΦ. The activated CasΦ collaterally cleaves the linker, releasing the fluophore to recover its fluorescent signal. The cycle of stem-loop-cleavage/CasΦ-activation/fluorescence-recovery amplifies the detection signal. Our target amplification-free collateral-cleavage-enhancing CRISPR-CasΦ method (TCC), with a detection limit of 0.11 copies/μL, demonstrates enhanced sensitivity compared to qPCR. It can detect pathogenic bacteria as low as 1.2 CFU/mL in serum within 40 min.
- 26 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Top Cited PapersOpen AccessUltrasensitive detection of clinical pathogens through a target-amplification-free collateral-cleavage-enhancing CRISPR-CasΦ tool
Clinical pathogen diagnostics detect targets by qPCR (but with low sensitivity) or blood culturing (but time-consuming). Here we leverage a dual-stem-loop DNA amplifier to enhance non-specific collateral enzymatic cleavage of an oligonucleotide linker between a fluophore and its quencher by CRISPR-CasΦ, achieving ultrasensitive target detection. Specifically, the target pathogens are lysed to release DNA, which binds its complementary gRNA in CRISPR-CasΦ to activate the collateral DNA-cleavage capability of CasΦ, enabling CasΦ to cleave the stem-loops in the amplifier. The cleavage product binds its complementary gRNA in another CRISPR-CasΦ to activate more CasΦ. The activated CasΦ collaterally cleaves the linker, releasing the fluophore to recover its fluorescent signal. The cycle of stem-loop-cleavage/CasΦ-activation/fluorescence-recovery amplifies the detection signal. Our target amplification-free collateral-cleavage-enhancing CRISPR-CasΦ method (TCC), with a detection limit of 0.11 copies/μL, demonstrates enhanced sensitivity compared to qPCR. It can detect pathogenic bacteria as low as 1.2 CFU/mL in serum within 40 min.
- 4 January 2025
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 150 (7) , 1235-1247
Real-time microbial growth curve (RMGC) system: an improved microplate reader with a graphical interface for automatic and high-throughput monitoring of microbial growth curves
The study of microbial growth curves is essential for comprehending microbial behavior and enhancing related processes. Current monitoring methods face limitations, including low automation, inefficient detection, and insufficient throughput. To address these challenges, we developed the Real-Time Microbial Growth Curve (RMGC) system, which offers fully automated and high-throughput monitoring of microbial growth through an Improved Microplate Reader (IMR) with a user-friendly graphical interface. By optimizing and calibrating the optical pathways, we achieve high-precision and consistent absorbance detection using LED light sources, surpassing traditional xenon lamp microplate readers, which lack continuous operation capabilities. We validated the RMGC system by cultivating 96 samples of Escherichia coli (E. coli) at a concentration of 105 CFU mL−1. After approximately 12 hours of continuous monitoring, the system exhibited a relative standard deviation (RSD) of less than 3.25% for optical density (OD) measurements and an RSD of 2.52% for the point of inflection (POI). These results indicate a similar level of precision but a longer monitoring time compared to conventional microplate readers, reflecting the effectiveness of the RMGC system in accurately monitoring microbial growth. The RMGC system showcases its versatility through various applications, such as microorganism gradient cultures, anaerobic microbial cultures, and antimicrobial susceptibility testing (AST). Its capabilities have important implications for multiple industries, including pharmaceuticals for antibiotic development, food safety for microbial contamination testing, and microbiological research.
- 4 January 2025
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 150 (7) , 1235-1247
Real-time microbial growth curve (RMGC) system: an improved microplate reader with a graphical interface for automatic and high-throughput monitoring of microbial growth curves
The study of microbial growth curves is essential for comprehending microbial behavior and enhancing related processes. Current monitoring methods face limitations, including low automation, inefficient detection, and insufficient throughput. To address these challenges, we developed the Real-Time Microbial Growth Curve (RMGC) system, which offers fully automated and high-throughput monitoring of microbial growth through an Improved Microplate Reader (IMR) with a user-friendly graphical interface. By optimizing and calibrating the optical pathways, we achieve high-precision and consistent absorbance detection using LED light sources, surpassing traditional xenon lamp microplate readers, which lack continuous operation capabilities. We validated the RMGC system by cultivating 96 samples of Escherichia coli (E. coli) at a concentration of 105 CFU mL−1. After approximately 12 hours of continuous monitoring, the system exhibited a relative standard deviation (RSD) of less than 3.25% for optical density (OD) measurements and an RSD of 2.52% for the point of inflection (POI). These results indicate a similar level of precision but a longer monitoring time compared to conventional microplate readers, reflecting the effectiveness of the RMGC system in accurately monitoring microbial growth. The RMGC system showcases its versatility through various applications, such as microorganism gradient cultures, anaerobic microbial cultures, and antimicrobial susceptibility testing (AST). Its capabilities have important implications for multiple industries, including pharmaceuticals for antibiotic development, food safety for microbial contamination testing, and microbiological research.
- 2 June 2023
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1271, 341470
Ligation-dependent Cas14a1-Activated biosensor for one-pot pathogen diagnostic
- 2 June 2023
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1271, 341470
Ligation-dependent Cas14a1-Activated biosensor for one-pot pathogen diagnostic
- Open Access
- 19 December 2022
- Published by American Chemical Society (ACS) in ChemRxiv
Ligation-Dependent Cas14a1-Activated Biosensor for One-pot Pathogenic Diagnostic
Pathogenic identification requires nucleic acid diagnosis with simple equipment and fast manipulation. Our work established an all-in-one strategy assay with excellent sensitivity and high specificity, Transcription-Amplified Cas14a1-Activated Signal Biosensor (TACAS), for the fluorescence-based bacterial RNA detection. The DNA as a promoter probe and a reporter probe directly ligated via SplintR ligase once specifically hybridized to the single-stranded target RNA sequence, with the ligation product transcribed into Cas14a1 RNA activators by T7 RNA polymerase. This forming sustained isothermal one-pot ligation-transcription cascade produced RNA activators constantly and enabled Cas14a1/sgRNA complex to generate fluorescence signal, thus leading to a sensitive detection limit of 1 CFU/mL E.coli within 2-3 h of incubation time. TACAS was applied in contrived E.coli infected fish samples, and a significant signal differentiation between positive (infected) and negative (uninfected) samples was reached. Meanwhile, E.coli colonization and transmit time in vivo were explored and the TACAS assay promoted the understanding of the infection mechanisms of the E.coli infection, demonstrating an excellent detection capability.
- 19 December 2022
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessLigation-Dependent Cas14a1-Activated Biosensor for One-pot Pathogenic Diagnostic
Pathogenic identification requires nucleic acid diagnosis with simple equipment and fast manipulation. Our work established an all-in-one strategy assay with excellent sensitivity and high specificity, Transcription-Amplified Cas14a1-Activated Signal Biosensor (TACAS), for the fluorescence-based bacterial RNA detection. The DNA as a promoter probe and a reporter probe directly ligated via SplintR ligase once specifically hybridized to the single-stranded target RNA sequence, with the ligation product transcribed into Cas14a1 RNA activators by T7 RNA polymerase. This forming sustained isothermal one-pot ligation-transcription cascade produced RNA activators constantly and enabled Cas14a1/sgRNA complex to generate fluorescence signal, thus leading to a sensitive detection limit of 1 CFU/mL E.coli within 2-3 h of incubation time. TACAS was applied in contrived E.coli infected fish samples, and a significant signal differentiation between positive (infected) and negative (uninfected) samples was reached. Meanwhile, E.coli colonization and transmit time in vivo were explored and the TACAS assay promoted the understanding of the infection mechanisms of the E.coli infection, demonstrating an excellent detection capability.